FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2222911000001102: CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25321901000001119 CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65922601000001117 CoAprovel 300mg/12.5mg tablets (Sanofi) 28 tablet 2 x 14 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Is a Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Is pack of CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) false Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has active ingredient Irbesartan false Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has AMP CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Irbesartan true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
CoAprovel 300mg/12.5mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start